跳至主要内容
临床试验/NCT03983200
NCT03983200Unknown不适用

Effect of Rotating Magnetic Therapy on Diabetic Peripheral Neuropathy

Majianhua0 个研究点目标入组 200 人开始时间: 2019年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
主要终点
Nerve conduction velocity examination

研究概览

简要总结

The aim of the study is to assess the effect of Rotating Magnetic Therapy on Diabetic Peripheral Neuropathy using Nerve conduction velocity examination.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Volunteer to participate and sign informed consent prior to the study
  • Patients with type 2 diabetes, who met WHO1999 diagnostic criteria, had diabetes distal symmetrical multiple neuropathy (1) clear history of diabetes; (2) neuropathy at or after diagnosis of diabetes;(3) clinical manifestations and signs are consistent with DPN;(4) have clinical symptoms (pain, numbness, paresthesia, etc.), 5 examination (ankle reflex, acupuncture pain sense, vibration sense, pressure sense, temperature sense) any 1 abnormal;If there were no clinical symptoms, 2 of the 5 examinations were abnormal.(5) exclude other causes of neuropathy).
  • HbA1c<7.5%, the hypoglycemic regimen was stable for 3 months
  • No acute complications, such as diabetic ketoacidosis, diabetic hyperosmolar syndrome, etc.

排除标准

  • Patients with foreign metal bodies or pacemakers
  • Patients with a history of surgery at magnetic therapy sites within one year
  • Patients with obvious discomfort to magnetic therapy
  • Patients with bleeding or bleeding tendency
  • Patients with acute complications such as diabetic ketoacidosis
  • Impaired liver and kidney function with ALT 2.5 times higher than the upper limit of normal value;Serum creatinine was 1.3 times higher than the upper limit of normal
  • History of drug abuse and alcohol dependence in the past 5 years
  • Systemic hormone therapy was used in the last three months
  • Patients with infection and stress within 4 weeks
  • Patients who are pregnant, breast-feeding, or intending to become pregnant.
  • Any other obvious conditions or co-existing diseases determined by the researcher: such as severe cardiopulmonary diseases, endocrine diseases, neurological diseases, tumors, other pancreatic diseases, patients with a history of mental illness, or severe wasting diseases

研究组 & 干预措施

Control group

Sham Comparator

Mecobalamine 0.5mg, tid

干预措施: Mecobalamin (Drug)

Rotating Magnetic Therapy

Experimental

Rotating Magnetic Therapy 30min,bid + Mecobalamine 0.5mg, tid

干预措施: Rotating Magnetic Therapy (Device)

Rotating Magnetic Therapy

Experimental

Rotating Magnetic Therapy 30min,bid + Mecobalamine 0.5mg, tid

干预措施: Mecobalamin (Drug)

结局指标

主要结局

Nerve conduction velocity examination

时间窗: 1 month

the change of Nerve conduction velocity examination

次要结局

  • Glycosylated serum albumin(1 month)
  • MNSI(1 month)

研究者

发起方
Majianhua
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Majianhua

Director, Head of Endocrinology department, Clinical Professor

Nanjing First Hospital, Nanjing Medical University

相似试验

Effect of Rotating Magnetic Therapy on Diabetic... | 临床试验